Heparin Nasal spray Trial to start.

[drron]

An Australian trial is to begin with a Haparin nasal spray as treatment if exposed to covid or for early treatment.

The collaborative team has successfully replicated international findings which show that heparin can indeed block the infection of nasal epithelial cells in culture by COVID-19, and therefore potentially prevent infection. Furthermore, it could also provide the same function in preventing infection and therefore transmission of influenza, the common cold, RSV, and other upper respiratory viral infections.

Nasal spray to combat COVID-19 heads to clinical trial

Nasal spray to combat COVID-19 heads to clinical trial

racp.readz.com